Antimicrobial Resistance

KNOW Antimicrobial Resistance

One in four infections in long-term acute care settings are caused by antibiotic resistant bacteria.¹

KNOW AMR is an initiative by Pfizer aimed at addressing the growing problem of antimicrobial resistance. This initiative focuses on raising awareness, promoting research, and implementing strategies to combat AMR and preserve the effectiveness of antimicrobial treatments.

Let’s Understand Antimicrobial Resistance

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread and severe illness.²

AMR can affect anyone, of any age, in any country. The World Health Organization (WHO) characterizes AMR as one of the biggest threats to global public health today.^3,5

Globally, AMR causes 700,000 deaths annually. If no solution is found, the devastating impact is likely to worsen.^4,5

• Serious bacerial infections could become impossible to treat.^4,5
• Many routine medical procedures could be too risky to perform because of the risk of becoming infected while in hospital by a multi-drug resistant pathogen.^5,6
• Minor infections and injuries could become life-threatening.^4,5
• Travel could be considered too risky, impacting global trade.^5,6
• Could lead to an estimated 10 million annual deaths by 2050.^5,6